2nd Edition of International Cancer and Precision Oncology Conference

Breakthroughs in oncology increasingly depend on precision-guided discovery, and the 2nd Edition of the International Cancer and Precision Oncology Conference (ICPOC 2026) provides an essential platform for this global dialogue. Scheduled for November 16–18, 2026, the Precision Oncology Conference will convene in Singapore while welcoming participants worldwide through a hybrid scientific format.
ICPOC 2026 is designed for oncologists, translational investigators, molecular scientists, genomic analysts, healthcare professionals, and industry contributors committed to individualized cancer management. The Cancer Conference highlights advancements that align molecular understanding with patient-specific therapeutic planning.
The scientific program addresses targeted treatment strategies, tumor-specific profiling, immunological modulation, biomarker development, precision diagnostics, and translational oncology pathways. Sessions emphasize clinical relevance, ensuring that research insights align with evolving care models.
Participants choosing virtual conference participation will gain access to live-streamed presentations, expert discussions, and interactive knowledge-sharing segments delivered via a digital platform. This approach ensures accessibility without compromising academic depth.
Upcoming Oncology Conferences fosters interdisciplinary exchange by connecting researchers, clinicians, and innovators from diverse healthcare environments. The event also promotes collaboration between academic institutions, biotechnology organizations, and healthcare systems.
By combining in-person engagement with remote scientific access, ICPOC 2026 offers flexibility for global professionals. The conference represents a valuable opportunity for learning, collaboration, and contribution within the expanding field of precision oncology, supporting progress toward improved cancer outcomes through personalized approaches.